PT - JOURNAL ARTICLE AU - Konstantina Zafeiropoulou AU - Emmeline G. Peters AU - Daan J. Brinkman AU - Andrew Y.F. Li Yim AU - Boudewijn J.J. Smeets AU - Theodorus B.M. Hakvoort AU - Evgeni Levin AU - Mark Davids AU - Misha D.P. Luyer AU - Wouter J. de Jonge AU - Joep P.M. Derikx TI - The preoperative abundance of <em>Prevotella</em> associates with anastomotic healing after colorectal surgery AID - 10.1101/2021.10.25.21265372 DP - 2021 Jan 01 TA - medRxiv PG - 2021.10.25.21265372 4099 - http://medrxiv.org/content/early/2021/10/26/2021.10.25.21265372.short 4100 - http://medrxiv.org/content/early/2021/10/26/2021.10.25.21265372.full AB - Anastomotic leakage (AL) is a frequent and potentially life-threatening postoperative complication in patients undergoing colorectal surgery with a multifactorial yet unknown pathophysiology. In the present study, we aimed to unravel AL etiology and intestinal anastomotic healing (AH) physiology focusing on both host epithelial and gut microbial components. We make use of patients-related samples and two high throughput next generation sequencing analysis approaches, including anastomotic tissue-associated bulk RNA sequencing and preoperative fecal 16S rRNA gene sequencing. We find that in the absence of host epithelial gene expression differences, the preoperative fecal microbiota of patients who undergo colorectal resection with successful AH differs in the group of patients who develop AL in the abundance of Prevotella and suggests a potential beneficial role of Prevotella that may prove useful as predictive biomarker for AH.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT02175979Funding StatementJ.D. and W.J are funded by the Dutch Research Council (ZonMW-NWO) research program Vidi project, No. 91719343 and AMC-stipendium 200402.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the Medical Ethics Committee of the Catharina Hospital. Informed consent was obtained from all subjects.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.